Senators Reintroduce Bill to Study Foreign Investment Impact on Pharmaceutical Supply Chains
Sens. Elizabeth Warren, D-Mass., and Marco Rubio, R-Fla., reintroduced a bill that would require the Federal Trade Commission, in consultation with the Commerce Department, to write a report on the effects of foreign investment in U.S. pharmaceutical supply chains. The…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
senators said their bill would provide information that would help the U.S. reduce its dependence on potentially unreliable imports, including ingredients used in generic drugs. The United States Pharmaceutical Supply Chain Review Act was referred to the Senate Banking Committee.